By Benjamin Chiou
Date: Wednesday 09 Jul 2025
(Sharecast News) - American pharma giant Merck announced on Wednesday that it is to pay $10bn for UK-based respiratory disease specialist Verona Pharma.
No recent information was found.
Currency | US Dollars |
Share Price | $ 80.40 |
Closing Price Change | $ -1.11 |
% Change | 0.00 % |
52 Week High | $115.63 |
52 Week Low | $73.47 |
Volume | 0 |
Shares Issued | 2,527.64m |
Beta | 0.35 |
RiskGrade | 92 |
Strong Buy | 7 |
Buy | 7 |
Neutral | 13 |
Sell | 0 |
Strong Sell | 0 |
Total | 27 |
You are here: research